SOD2 is a regulator of proteasomal degradation promoting an adaptive cellular starvation response

Nurul Khalida Ibrahim(Medizinische Hochschule Hannover), Laura Hinze(Boston Children's Hospital), Martin Stanulla(Leibniz University Hannover), Evgeni Ponimaskin(Medizinische Hochschule Hannover), André Zeug(Medizinische Hochschule Hannover), Anna Sophie Stasche(Medizinische Hochschule Hannover), Alejandro Gutiérrez(Boston Children's Hospital), Sabine Schreek(Medizinische Hochschule Hannover), Jean‐Pierre Bourquin(University Children's Hospital Zurich), Halyna R. Shcherbata(Mount Desert Island Biological Laboratory), Beate Fehlhaber(Medizinische Hochschule Hannover), Tim Dolgner(Medizinische Hochschule Hannover), Su Hyun Lee(Seoul National University), Andreas Pich(Medizinische Hochschule Hannover), Buesra Cinar(Medizinische Hochschule Hannover), Beat Bornhäuser(University Children's Hospital Zurich)
Cell Reports
March 24, 2025
10.1016/j.celrep.2025.115434
Cited by 5

Related Papers

Cardiac fibroblast–derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy
|Journal of Clinical Investigation|2014|993
METTL1-mediated m7G modification of Arg-TCT tRNA drives oncogenic transformation
|Molecular Cell|2021|359
Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group
|Blood|2009|347
Induction of autophagy-dependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance
|Journal of Clinical Investigation|2010|311
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice
|Cancer Cell|2016|304